110
Participants
Start Date
December 31, 2010
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Degarelix
Degarelix was given as subcutaneous (s.c.) injections with a 240 mg starting dose followed one month later by a 80 mg maintenance dose. The maintenance dosing was repeated for an additional 5 months (total treatment period was 168 days).
Changhua Christian Hospital, Changhua
Chang Gung Medical Foundation, Chiayi Branch, Chiayi City
Chang Gung Memorial Hospital, Kaohsiung, Kaohsiung City
Kaohsiung Veterans General Hospital, Kaohsiung City
China Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
Chi-Mei Foundation Hospital, Tainan City
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Chang Gung Memorial Hospital, Linkuo, Taoyuan District
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY